Key result
The Electronic CardioMetabolic Program (eCMP) did not significantly improve health-related quality of life compared to a wait-list control group at 3 months, but did produce significant weight loss.
Why the study?
Does the Electronic Cardio-Metabolic Program (eCMP) improve health-related quality of life in adults with cardiometabolic risk?
Population
74 adults aged ≥18 years with cardiometabolic risk, mean age 59.7 years, 59.5% female, 82.4% white. Key…
Comparison
Electronic Cardio-Metabolic Program immediately… vs Wait-list control.
Design
RCT, Randomized, wait-list controlled, Blinded outcome assessments
Follow-up
6 months
Authors
Loading...
No HRQoL benefit from eCMP; extends RCT evidence for digital programs achieving weight loss in cardiometabolic risk.
RCT (n=74)
Blinded outcome assessors
Dynamic block randomization
No
Does the Electronic Cardio-Metabolic Program (eCMP) improve health-related quality of life in adults with cardiometabolic risk?
Absolute Event Rate: 1.5% vs -1.3%
The eCMP lifestyle intervention did not significantly improve quality of life but was feasible, well-accepted, and associated with weight loss and reduced waist circumference.
Azar et al. (2016) conducted an RCT in Cardiometabolic Risk (n=74). Electronic CardioMetabolic Program (eCMP) vs. Wait-list control was evaluated on Health-related quality of life (SF-8 mental component change at 3 months) (95% CI -6.6 to 1.0). The Electronic CardioMetabolic Program (eCMP) did not significantly improve health-related quality of life compared to a wait-list control group at 3 months, but did produce significant weight loss.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: